Cartesian Therapeutics, Inc.
RNAC
$6.49
-$0.17-2.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -130.30M | -47.98M | -36.26M | -38.31M | -77.42M |
| Total Depreciation and Amortization | 2.96M | 2.84M | 2.52M | 2.12M | 1.15M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 61.47M | -16.88M | -24.26M | 11.83M | 58.39M |
| Change in Net Operating Assets | -8.06M | -1.21M | 24.07M | -6.50M | -5.79M |
| Cash from Operations | -73.94M | -63.23M | -33.94M | -30.87M | -23.67M |
| Capital Expenditure | -5.45M | -5.67M | -10.57M | -9.57M | -9.09M |
| Sale of Property, Plant, and Equipment | -- | 351.00K | 351.00K | 351.00K | 351.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.45M | -5.32M | -10.22M | -9.22M | -8.74M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 323.00K | 1.12M | 125.61M | 125.65M | 128.49M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 0.00 | 40.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.38M | -8.34M | -8.30M | -8.27M | -66.00K |
| Cash from Financing | -8.06M | -7.22M | 117.31M | 117.37M | 168.43M |
| Foreign Exchange rate Adjustments | 45.00K | 19.00K | 14.00K | 16.00K | -21.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -87.41M | -75.75M | 73.16M | 77.31M | 135.99M |